APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug Containment Solution

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Drug Containment Solution Market Outlook and Growth Opportunities 2026

4 July 2026193 pages

Choose your research edition.

Industry ResearchDrug Containment Solution Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Containment Solution Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Drug Containment Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Containment Solution Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Containment Solution Market Analysis and Forecast 2026-2032179 pages · $4,950 USD

Market perspective

The global Drug Containment Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Drug Containment Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Drug Containment Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drug Containment Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Drug Containment Solution market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Drug Containment Solution market include Stevanato Group, BD, AptarGroup, Hergesheimer AG, Catalent, Inc., West Pharmaceutical Services, Inc., Schott AG, Stearate Group and NIPRO, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Drug Containment Solution market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drug Containment Solution and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drug Containment Solution revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Drug Containment Solution market.

Drug Containment Solution Segment by Company

Stevanato Group

BD

AptarGroup

Hergesheimer AG

Catalent, Inc.

West Pharmaceutical Services, Inc.

Schott AG

Stearate Group

NIPRO

Owen Mumford Limited

Psalmed AG

Drug Containment Solution Segment by Type

Vials

Ampoules

Bottles

Drug Containment Solution Segment by Application

Hospitals

Clinics

Home Care Settings

Ambulatory Surgical Centers

Drug Containment Solution Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Drug Containment Solution status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Drug Containment Solution key companies, revenue, market share, and recent developments.

3. To split the Drug Containment Solution breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Drug Containment Solution market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Drug Containment Solution significant trends, drivers, influence factors in global and regions.

6. To analyze Drug Containment Solution competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Containment Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Containment Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Containment Solution.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drug Containment Solution industry.

Chapter 3: Detailed analysis of Drug Containment Solution company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Drug Containment Solution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Drug Containment Solution in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Drug Containment Solution Industry Trends Table 2. Drug Containment Solution Industry Drivers Table 3. Drug Containment Solution Industry Opportunities and Challenges Table 4. Drug Containment Solution Industry Restraints Table 5. Global Drug Containment Solution Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Drug Containment Solution Revenue Share by Company (2021-2026) Table 7. Global Drug Containment Solution Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Drug Containment Solution Key Company Manufacturing Base & Headquarters Table 9. Global Drug Containment Solution Company, Product Type & Application Table 10. Global Drug Containment Solution Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Drug Containment Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Vials Table 15. Significant Companies of Ampoules Table 16. Significant Companies of Bottles Table 17. Global Drug Containment Solution Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Drug Containment Solution Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Drug Containment Solution Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Drug Containment Solution Sales Value Share by Type (2021-2026) Table 21. Global Drug Containment Solution Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospitals Table 23. Significant Companies of Clinics Table 24. Significant Companies of Home Care Settings Table 25. Significant Companies of Ambulatory Surgical Centers Table 26. Global Drug Containment Solution Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Drug Containment Solution Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Drug Containment Solution Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Drug Containment Solution Sales Value Share by Application (2021-2026) Table 30. Global Drug Containment Solution Sales Value Share by Application (2027-2032) Table 31. Global Drug Containment Solution Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Drug Containment Solution Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Drug Containment Solution Sales Value Share by Region (2021-2026) Table 34. Global Drug Containment Solution Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Drug Containment Solution Sales Value Share by Region (2027-2032) Table 36. Global Drug Containment Solution Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Drug Containment Solution Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Drug Containment Solution Sales Value Market Share by Country (2021-2026) Table 39. Global Drug Containment Solution Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Drug Containment Solution Sales Value Market Share by Country (2027-2032) Table 41. Stevanato Group Company Information Table 42. Stevanato Group Business Overview Table 43. Stevanato Group Drug Containment Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Stevanato Group Drug Containment Solution Product Portfolio Table 45. Stevanato Group Recent Development Table 46. BD Company Information Table 47. BD Business Overview Table 48. BD Drug Containment Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. BD Drug Containment Solution Product Portfolio Table 50. BD Recent Development Table 51. AptarGroup Company Information Table 52. AptarGroup Business Overview Table 53. AptarGroup Drug Containment Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. AptarGroup Drug Containment Solution Product Portfolio Table 55. AptarGroup Recent Development Table 56. Hergesheimer AG Company Information Table 57. Hergesheimer AG Business Overview Table 58. Hergesheimer AG Drug Containment Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Hergesheimer AG Drug Containment Solution Product Portfolio Table 60. Hergesheimer AG Recent Development Table 61. Catalent, Inc. Company Information Table 62. Catalent, Inc. Business Overview Table 63. Catalent, Inc. Drug Containment Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Catalent, Inc. Drug Containment Solution Product Portfolio Table 65. Catalent, Inc. Recent Development Table 66. West Pharmaceutical Services, Inc. Company Information Table 67. West Pharmaceutical Services, Inc. Business Overview Table 68. West Pharmaceutical Services, Inc. Drug Containment Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. West Pharmaceutical Services, Inc. Drug Containment Solution Product Portfolio Table 70. West Pharmaceutical Services, Inc. Recent Development Table 71. Schott AG Company Information Table 72. Schott AG Business Overview Table 73. Schott AG Drug Containment Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Schott AG Drug Containment Solution Product Portfolio Table 75. Schott AG Recent Development Table 76. Stearate Group Company Information Table 77. Stearate Group Business Overview Table 78. Stearate Group Drug Containment Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Stearate Group Drug Containment Solution Product Portfolio Table 80. Stearate Group Recent Development Table 81. NIPRO Company Information Table 82. NIPRO Business Overview Table 83. NIPRO Drug Containment Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. NIPRO Drug Containment Solution Product Portfolio Table 85. NIPRO Recent Development Table 86. Owen Mumford Limited Company Information Table 87. Owen Mumford Limited Business Overview Table 88. Owen Mumford Limited Drug Containment Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Owen Mumford Limited Drug Containment Solution Product Portfolio Table 90. Owen Mumford Limited Recent Development Table 91. Psalmed AG Company Information Table 92. Psalmed AG Business Overview Table 93. Psalmed AG Drug Containment Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Psalmed AG Drug Containment Solution Product Portfolio Table 95. Psalmed AG Recent Development Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. Drug Containment Solution Product Image Figure 2. Global Drug Containment Solution Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug Containment Solution Market Size (2021-2032) & (US$ Million) Figure 4. Global Drug Containment Solution Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Vials Image Figure 8. Ampoules Image Figure 9. Bottles Image Figure 10. Global Drug Containment Solution Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Drug Containment Solution Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Drug Containment Solution Sales Value Share by Type (2021-2032) Figure 13. Hospitals Image Figure 14. Clinics Image Figure 15. Home Care Settings Image Figure 16. Ambulatory Surgical Centers Image Figure 17. Global Drug Containment Solution Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Drug Containment Solution Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Drug Containment Solution Sales Value Share by Application (2021-2032) Figure 20. Global Drug Containment Solution Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Drug Containment Solution Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Drug Containment Solution Sales Value (2021-2032) & (US$ Million) Figure 23. North America Drug Containment Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Drug Containment Solution Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Drug Containment Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Drug Containment Solution Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Drug Containment Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Drug Containment Solution Sales Value (2021-2032) & (US$ Million) Figure 29. South America Drug Containment Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Drug Containment Solution Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Drug Containment Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Drug Containment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Drug Containment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Drug Containment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Drug Containment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Drug Containment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Drug Containment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Drug Containment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Drug Containment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Drug Containment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Drug Containment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Drug Containment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Drug Containment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Drug Containment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Drug Containment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Drug Containment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Drug Containment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Drug Containment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Drug Containment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Drug Containment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Drug Containment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Drug Containment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Drug Containment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Drug Containment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Drug Containment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Drug Containment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Drug Containment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Drug Containment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Drug Containment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Drug Containment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Drug Containment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Drug Containment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Drug Containment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Drug Containment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Drug Containment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Drug Containment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Drug Containment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Drug Containment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Drug Containment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Drug Containment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Drug Containment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Drug Containment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Drug Containment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Drug Containment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Drug Containment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Drug Containment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Drug Containment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Drug Containment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Drug Containment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Drug Containment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Drug Containment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Drug Containment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Drug Containment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Drug Containment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Drug Containment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Drug Containment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Drug Containment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Drug Containment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Drug Containment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Drug Containment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Drug Containment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Drug Containment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Drug Containment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Drug Containment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Drug Containment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Drug Containment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Drug Containment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Drug Containment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Drug Containment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Drug Containment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Drug Containment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Drug Containment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Drug Containment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Drug Containment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Drug Containment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Drug Containment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Drug Containment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Drug Containment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Drug Containment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Drug Containment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Drug Containment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Drug Containment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Drug Containment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Drug Containment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Drug Containment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Vials
  • Ampoules
  • Bottles
Applications
  • Hospitals
  • Clinics
  • Home Care Settings
  • Ambulatory Surgical Centers
Companies covered
  • Stevanato Group
  • BD
  • AptarGroup
  • Hergesheimer AG
  • Catalent, Inc.
  • West Pharmaceutical Services, Inc.
  • Schott AG
  • Stearate Group
  • NIPRO
  • Owen Mumford Limited
  • Psalmed AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Drug Containment Solution Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Drug Containment Solution Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Drug Containment Solution Market Dynamics
  1. 2.1 Drug Containment Solution Industry Trends
  2. 2.2 Drug Containment Solution Industry Drivers
  3. 2.3 Drug Containment Solution Industry Opportunities and Challenges
  4. 2.4 Drug Containment Solution Industry Restraints
3 Drug Containment Solution Market by Company
  1. 3.1 Global Drug Containment Solution Company Revenue Ranking in 2025
  2. 3.2 Global Drug Containment Solution Revenue by Company (2021-2026)
  3. 3.3 Global Drug Containment Solution Company Ranking (2024-2026)
  4. 3.4 Global Drug Containment Solution Company Manufacturing Base and Headquarters
  5. 3.5 Global Drug Containment Solution Company Product Type and Application
  6. 3.6 Global Drug Containment Solution Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Drug Containment Solution Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Drug Containment Solution Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Drug Containment Solution Market by Type
  1. 4.1 Drug Containment Solution Type Introduction
  2. 4.1.1 Vials
  3. 4.1.2 Ampoules
  4. 4.1.3 Bottles
  5. 4.2 Global Drug Containment Solution Sales Value by Type
  6. 4.2.1 Global Drug Containment Solution Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Drug Containment Solution Sales Value by Type (2021-2032)
  8. 4.2.3 Global Drug Containment Solution Sales Value Share by Type (2021-2032)
5 Drug Containment Solution Market by Application
  1. 5.1 Drug Containment Solution Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Home Care Settings
  5. 5.1.4 Ambulatory Surgical Centers
  6. 5.2 Global Drug Containment Solution Sales Value by Application
  7. 5.2.1 Global Drug Containment Solution Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Drug Containment Solution Sales Value by Application (2021-2032)
  9. 5.2.3 Global Drug Containment Solution Sales Value Share by Application (2021-2032)
6 Drug Containment Solution Regional Value Analysis
  1. 6.1 Global Drug Containment Solution Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Drug Containment Solution Sales Value by Region (2021-2032)
  3. 6.2.1 Global Drug Containment Solution Sales Value by Region: 2021-2026
  4. 6.2.2 Global Drug Containment Solution Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Drug Containment Solution Sales Value (2021-2032)
  7. 6.3.2 North America Drug Containment Solution Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Drug Containment Solution Sales Value (2021-2032)
  10. 6.4.2 Europe Drug Containment Solution Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Drug Containment Solution Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Drug Containment Solution Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Drug Containment Solution Sales Value (2021-2032)
  16. 6.6.2 South America Drug Containment Solution Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Drug Containment Solution Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Drug Containment Solution Sales Value Share by Country, 2025 VS 2032
7 Drug Containment Solution Country-level Value Analysis
  1. 7.1 Global Drug Containment Solution Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Drug Containment Solution Sales Value by Country (2021-2032)
  3. 7.2.1 Global Drug Containment Solution Sales Value by Country (2021-2026)
  4. 7.2.2 Global Drug Containment Solution Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Drug Containment Solution Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Drug Containment Solution Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Drug Containment Solution Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Drug Containment Solution Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Drug Containment Solution Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Drug Containment Solution Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Drug Containment Solution Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Drug Containment Solution Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Drug Containment Solution Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Drug Containment Solution Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Drug Containment Solution Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Drug Containment Solution Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Drug Containment Solution Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Drug Containment Solution Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Drug Containment Solution Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Drug Containment Solution Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Drug Containment Solution Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Drug Containment Solution Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Drug Containment Solution Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Drug Containment Solution Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Drug Containment Solution Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Drug Containment Solution Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Drug Containment Solution Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Drug Containment Solution Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Drug Containment Solution Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Drug Containment Solution Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Drug Containment Solution Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Drug Containment Solution Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Drug Containment Solution Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Drug Containment Solution Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Drug Containment Solution Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Drug Containment Solution Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Drug Containment Solution Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Drug Containment Solution Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Drug Containment Solution Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Drug Containment Solution Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Drug Containment Solution Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Drug Containment Solution Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Drug Containment Solution Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Drug Containment Solution Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Drug Containment Solution Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Drug Containment Solution Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Drug Containment Solution Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Drug Containment Solution Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Drug Containment Solution Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Drug Containment Solution Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Drug Containment Solution Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Drug Containment Solution Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Drug Containment Solution Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Drug Containment Solution Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Drug Containment Solution Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Drug Containment Solution Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Drug Containment Solution Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Drug Containment Solution Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Drug Containment Solution Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Drug Containment Solution Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Drug Containment Solution Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Drug Containment Solution Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Drug Containment Solution Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Drug Containment Solution Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Drug Containment Solution Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Drug Containment Solution Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Drug Containment Solution Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Drug Containment Solution Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Drug Containment Solution Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Drug Containment Solution Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Drug Containment Solution Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Drug Containment Solution Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Drug Containment Solution Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Drug Containment Solution Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Drug Containment Solution Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Drug Containment Solution Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Drug Containment Solution Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Drug Containment Solution Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Drug Containment Solution Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Drug Containment Solution Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Drug Containment Solution Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Drug Containment Solution Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Drug Containment Solution Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Drug Containment Solution Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Drug Containment Solution Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Drug Containment Solution Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Drug Containment Solution Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Drug Containment Solution Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Stevanato Group
  2. 8.1.1 Stevanato Group Company Information
  3. 8.1.2 Stevanato Group Business Overview
  4. 8.1.3 Stevanato Group Drug Containment Solution Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Stevanato Group Drug Containment Solution Product Portfolio
  6. 8.1.5 Stevanato Group Recent Developments
  7. 8.2 BD
  8. 8.2.1 BD Company Information
  9. 8.2.2 BD Business Overview
  10. 8.2.3 BD Drug Containment Solution Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BD Drug Containment Solution Product Portfolio
  12. 8.2.5 BD Recent Developments
  13. 8.3 AptarGroup
  14. 8.3.1 AptarGroup Company Information
  15. 8.3.2 AptarGroup Business Overview
  16. 8.3.3 AptarGroup Drug Containment Solution Revenue and Gross Margin (2021-2026)
  17. 8.3.4 AptarGroup Drug Containment Solution Product Portfolio
  18. 8.3.5 AptarGroup Recent Developments
  19. 8.4 Hergesheimer AG
  20. 8.4.1 Hergesheimer AG Company Information
  21. 8.4.2 Hergesheimer AG Business Overview
  22. 8.4.3 Hergesheimer AG Drug Containment Solution Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hergesheimer AG Drug Containment Solution Product Portfolio
  24. 8.4.5 Hergesheimer AG Recent Developments
  25. 8.5 Catalent, Inc.
  26. 8.5.1 Catalent, Inc. Company Information
  27. 8.5.2 Catalent, Inc. Business Overview
  28. 8.5.3 Catalent, Inc. Drug Containment Solution Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Catalent, Inc. Drug Containment Solution Product Portfolio
  30. 8.5.5 Catalent, Inc. Recent Developments
  31. 8.6 West Pharmaceutical Services, Inc.
  32. 8.6.1 West Pharmaceutical Services, Inc. Company Information
  33. 8.6.2 West Pharmaceutical Services, Inc. Business Overview
  34. 8.6.3 West Pharmaceutical Services, Inc. Drug Containment Solution Revenue and Gross Margin (2021-2026)
  35. 8.6.4 West Pharmaceutical Services, Inc. Drug Containment Solution Product Portfolio
  36. 8.6.5 West Pharmaceutical Services, Inc. Recent Developments
  37. 8.7 Schott AG
  38. 8.7.1 Schott AG Company Information
  39. 8.7.2 Schott AG Business Overview
  40. 8.7.3 Schott AG Drug Containment Solution Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Schott AG Drug Containment Solution Product Portfolio
  42. 8.7.5 Schott AG Recent Developments
  43. 8.8 Stearate Group
  44. 8.8.1 Stearate Group Company Information
  45. 8.8.2 Stearate Group Business Overview
  46. 8.8.3 Stearate Group Drug Containment Solution Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Stearate Group Drug Containment Solution Product Portfolio
  48. 8.8.5 Stearate Group Recent Developments
  49. 8.9 NIPRO
  50. 8.9.1 NIPRO Company Information
  51. 8.9.2 NIPRO Business Overview
  52. 8.9.3 NIPRO Drug Containment Solution Revenue and Gross Margin (2021-2026)
  53. 8.9.4 NIPRO Drug Containment Solution Product Portfolio
  54. 8.9.5 NIPRO Recent Developments
  55. 8.10 Owen Mumford Limited
  56. 8.10.1 Owen Mumford Limited Company Information
  57. 8.10.2 Owen Mumford Limited Business Overview
  58. 8.10.3 Owen Mumford Limited Drug Containment Solution Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Owen Mumford Limited Drug Containment Solution Product Portfolio
  60. 8.10.5 Owen Mumford Limited Recent Developments
  61. 8.11 Psalmed AG
  62. 8.11.1 Psalmed AG Company Information
  63. 8.11.2 Psalmed AG Business Overview
  64. 8.11.3 Psalmed AG Drug Containment Solution Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Psalmed AG Drug Containment Solution Product Portfolio
  66. 8.11.5 Psalmed AG Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst